abpa panel test (Allergic Bronchopulmonary Aspergillosis) Test

Aspergillus Broncho Pulmonary Aspergillosis (ABPA) Panel, ImmunoCAP detects hypersensitivity to Aspergillus fumigatus that occurs in patients with asthma or cystic fibrosis by measuring Total IgE, Aspergillus fumigatus (Specific IgG), and Aspergillus fumigatus (Specific IgE). The test is also used to monitor treatment response in ABPA. You should consider the ABPA testing, if you notice symptoms similar to asthma including fever and chills, chest or joint pain, weight loss, wheezing, cough, coughing up blood, shortness of breath. When the ABPA test is positive, and the patient shows the presence of predisposing conditions like asthma or cystic fibrosis, it is indicative of hypersensitivity to Aspergillus fumigatus species. A negative result indicates that the symptoms are not due to Aspergillus fumigatus and other differential diagnoses must be considered.